The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 162-166

  Takeyama, Koh ^a   Mitsuzawa, Hiroaki ^a   Nishitani, Chiaki ^a   Shimizu, Takeyuki ^a   Sano, Hitomi ^a   Kunishima, Yasuharu ^a   Takahashi, Satoshi ^a   Hotta, Hiroshi ^a   Matsukawa, Masanori ^a   Shibata, Ken Ichiro ^b   Tsukamoto, Taiji ^a   Kuroki, Yoshio ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PEPTIDOGLYCAN; PHORBOL ESTER; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHRONIC PROSTATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FLANKING REGION; DRUG MECHANISM; GENE CONSTRUCT; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MALE; MONOCYTE; MYCOPLASMA HOMINIS; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE;

ANTI-INFECTIVE AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FLUOROQUINOLONES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; LUCIFERASES; MACROPHAGES; MALE; MONOCYTES; NF-KAPPA B; PEPTIDOGLYCAN; PHORBOL ESTERS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845996209     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00395-06     Document Type: Article

References (34)

1. Aagaard, J., J. Knes, and P. O. Madsen. 1991. Prostatic tissue levels of ofloxacin. Urology 38:380-382.
2. Alexander, R. B., S. Ponniah, J. Hasday, and J. R. Hebel. 1998. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 52:744-749.
3. Alexander, R. B., K. J. Propert, A. J. Schaeffer, R. Landis, J. C. Nickel, M. P. O'Leary, M. A. Pontari, M. McNaughton-Collins, D. A. Shosken, C. V. Comiter, N. S. Datta, J. E. Fowler, R. B. Nadler, S. Zeitlin, J. S. Knauss, Y. Wang, J. W. Kusek, L. M. Nyberg, M. S. Litwin, and C. P. R. Network. 2004. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann. Intern. Med. 141: 581-589.
4. Araujo, F. G., T. R. Slifer, and J. S. Remington. 2002. Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clin. Microbiol. Infect. 8:26-30.
5. Bailly, S., Y. Mahe, B. Ferrua, M. Fay, T. Tursz, H. Wakasugi, and M. A. Gougerot-Pocidalo. 1990. Quinolone-induced differential modification of interleukin 1α and interleukin 1β production by lipopolysaccharide- stimulated human monocytes. Cell. Immunol. 128:277-288.
6. Dalhoff, A., and I. Shalit. 2003. Immunomodulatory effects of quinolones. Lancet Infect. Dis. 3:359-371.
7. Flick, D. A., and G. E. Gifford. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68:167-175.
8. Galley, H. F., J. K. Dhillon, R. L. Paterson, and N. R. Webster. 2000. Effect of ciprofloxacin on the activation of the transcription factors nuclear factor κB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line. Clin. Sci. (London) 99:405-410.
9. Galley, H. F., S. J. Nelson, A. M. Duhhels, and N. R. Webster. 1997. Effect 7 of ciproxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial model of sepsis. Crit. Care Med. 25:1392-1395.
10. Hashimoto, S., K. Matsumoto, Y. Gon, S. Maruoka, S. Hayashi, Y. Asai, T. Machine, and T. Horie. 2000. Grepafloxacin inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in human airway epithelial cells. Life Sci. 66:PL77-PL82.
11. Hisataki, T., N. Itoh, K. Suzuki, A. Takahashi, N. Masumori, N. Tohse, Y. Ohmori, S. Yamada, and T. Tsukamoto. 2004. Modulation of phenotype of human prostatic stromal cells by trasnforming growth facor-beta. Prostate 58:174-182.
12. Hochreiter, W. W., R. B. Nalder, A. E. Koch, P. L. Campbell, M. Ludwig, W. Weidner, and A. J. Schaeffer. 2000. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 56:1025-1029.
13. Hosaka, M., T. Yasue, H. Fukuda, H. Tomizawa, H. Aoyama, and K. Hirai. 1992. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob. Agents Chemother. 36:2108-2117.
14. Into, T., Y. Nodasaka, A. Hasebe, T. Okuzawa, J. Nakamura, N. Ohata, and K. Shibata. 2002. Mycoplasmal lipoproteins induce Toll-like receptor 2- and caspase-mediated cell death in lymphocytes and monocytes. Microbiol. Immunol. 46:265-276.
15. Jang, T. L., and A. J. Schaeffer. 2003. The role of cytokines in prostatitis. World J. Urol. 21:95-99.
16. Kawada, Y., Y. Kumamoto, S. Orikasa, Y. Aso, T. Machida, I. Saito, N. Kawamura, K. Suzuki, K. Kawabe, K. Okada, Y. Naide, S. Kamidono, H. Ohmori, T. Usui, J. Kumazawa, and Y. Ohi. 1999. Clinical early phase II study of gatifloxacin in urinary tract infection. Jpn. J. Chemother. 47(Suppl. 2):292-307.
17. Kohnen, P. W., and G. W. Drach. 1979. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J. Urol. 121:755-760.
18. Miller, L. J., K. A. Fischer, M. L. Goralnick, J. A. Burleson, P. Albertsen, and D. Kreutzer. 2002. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J. Urol. 167:753-756.
19. Mukaida, N., A. Harada, K. Yasumoto, and K. Matsushima. 1992. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol. Immunol. 36:773-789.
20. Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143:1366-1371.
21. Naber, C. K., M. Steghafner, M. Kinzig-Schippers, C. Sauber, F. Sörgel, H. J. Stahlberg, and K. G. Naber. 2001. Concentration of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers. Antimicrob. Agents Chemother. 45:293-297.
22. Nadler, R. B., A. E. Koch, E. A. Calhoun, P. L. Campbell, D. L. Pruden, C. L. Bennett, P. R. Yarnold, and A. J. Schaeffer. 2000. IL-1β and TNF-α in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J. Urol. 164:214-218.
23. Nickel, J. C., J. Downey, B. Johnston, J. Clark, and the Canadian Prostatitis Research Group. 2001. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J. Urol. 165:1539-1544.
24. Olszyna, D. P., H. Vermeulen, A. H. Baan, P. Speelman, S. J. H. van Deventer, D. J. Gouma, and T. van der Poll. 2001. Urine interleukin-8 is a marker for urinary tract infection in postoperative patients. Infection 29: 274-277.
25. Ono, Y., Y. Ohmoto, K. Ouo, Y. Sakata, and K. Murata. 2000. Effect of grepafloxacin on cytokine production in vitro. J. Antimicrob. Chemother. 46:91-94.
26. Png, J. C. D., E. Tan, K. T. Foo, M. K. Li, C. Cheng, and I. R. Rekhraj. 1997. A comparative study of the distribution of floxacin and ciproxacin in prostatic tissues after simultaneous oral ingestion. Br. J. Urol. 79:781-784.
27. Pontari, M. A., and M. R. Ruggieri. 2004. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. 172:839-845.
28. Rao, W. H., G. S. Evans, and A. Finn. 2001. The significance of interleukin 8 in urine. Arch. Dis. Child. 85:256-262.
29. Schaeffer, A. J., J. S. Knauss, R. Landis, K. J. Propert, R. B. Alexander, M. S. Litwin, J. C. Nickel, M. P. O'Leary, R. B. Nadler, M. A. Pontari, D. A. Shoskes, S. Zeitlin, J. E. Fowler, C. A. Mazurick, J. W. Kusek, L. M. Nyberg, and the Chronic Prostatitis Collaborative Research Network Study Group. 2002. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J. Urol. 168:1048-1053.
30. Stunkel, K. G. E., G. Hewlett, and H. J. Zeiler. 1991. Ciprofloxacin enhances T cell function by modulating interleukin activities. Clin. Exp. Immunol. 86:525-531.
31. Weidner, W., H. G. Schiefer, H. Krauss, C. Jantos, H. J. Friedrich, and M. Altmannsberger. 1991. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 19: S119-S125.
32. Williams, A. C., H. F. Galley, and N. R. Webster. 2001. The effect of moxifloxacin on release of interleukin-8 from human neutrophils. Br. J. Anaesth. 87:671-672.
33. Yasumoto, R., M. Kawano, T. Tsujino, Y. Iwai, S. Hayashi, N. Nishisaka, A. Horii, and T. Kishimoto. 1995. Seminal plasma cytokines in nonbacterial prostatitis: changes following sparfloxacin treatment. Acta Urol. Jpn. 41: 771-774.
34. Yoshimura, T., C. Kurita, E. Usami, T. Nakao, S. Watanabe, J. Kobayashi, F. Yamazaki, and H. Nagai. 1996. Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells. Chemotherapy 42:459-464.